After the COVID-19 pandemic started clinical trials quickly sprouted up to test various kinds of cell therapy for COVID-19 including stem cells. The most common rationale for this approach is to suppress damaging overactive immune responses. Trials of cell therapy for COVID-19 including stem cells I’ve written quite a lot about these cellular medicine and […]
Our new paper assessing trials of cell therapy for COVID-19 Read More »
The first of the month often brings loads of new papers as new issues of journals come out so we have a wave of new stem cell papers. By the way, be sure to enter our stem cell picture contest to try to win $100 or a bundle of stem cell swag. There’s less than
Weekly reads: NIH genome editing, gut stem cells & diet, more Read More »
A few times a month I do a recommended reads kind of post on more than just stem cells, which people seem to appreciate as a condensed list of new science and medicine. Scientists might ask each other, “what’s in your to-read list?” rather than “what’s in your wallet?” Here are some of the things
Recommended reads: autism, cancer, & nucleosomes Read More »
I’m a biologist and genetics researcher, but as I have time I still squeeze in a little research on stem cell clinics when I can, and my new pub in Regenerative Medicine is notable for looking at changes in clinic firms in a unique kind of way. In the paper I went back to the
My Regenerative medicine pub tracking 100s of stem cell clinics over 3 years Read More »
What new papers and news in the stem cell sphere caught your eye? Here are some recent items that seem notable to me. Diabetes relief in mice by glucose-sensing insulin-secreting human α-cells. This paper reports cellular reprogramming to insulin-producing cells in mice. They reprogrammed α-cells with Pdx1 and MafA proteins. ‘Mitophagy inhibits amyloid-β and tau pathology and reverses
Recent stem cell pubs & news: reprogramming, chromatin, single-cell, Astellas, & more Read More »
I asked Nature a half dozen questions about their editorial process. While they declined to answer any direct questions about the STAP cell paper situation, I thank them for answering these questions via a Nature spokesperson. The end result is an intriguing glimpse inside the editorial/review process at Nature. 1. Does Nature have any kind
Interview with Nature on their editorial process in wake of STAP Read More »
What are the most important iPS cell papers so far? 1) Yamanaka’s first paper on mouse iPS cells. Revolutionary. Intriguing perspectives presented in day 1 of the iPS cell field. Interesting statements such as Myc is required. Also take a look at those other reprogramming factors that he tested…there’s a tremendous amount there, largely unexamined.
What are the best iPS cell papers so far? Read More »